Systematic analysis of mitochondrial genes associated with hearing loss in the Japanese population: dHPLC reveals a new candidate mutation by Mutai, Hideki et al.
RESEARCH ARTICLE Open Access
Systematic analysis of mitochondrial genes
associated with hearing loss in the Japanese
population: dHPLC reveals a new candidate
mutation
Hideki Mutai
1, Hiroko Kouike
1, Eiko Teruya
1, Ikuko Takahashi-Kodomari
1, Hiroki Kakishima
2, Hidenobu Taiji
3,
Shin-ichi Usami
4, Torayuki Okuyama
2 and Tatsuo Matsunaga
1*
Abstract
Background: Variants of mitochondrial DNA (mtDNA) have been evaluated for their association with hearing loss.
Although ethnic background affects the spectrum of mtDNA variants, systematic mutational analysis of mtDNA in
Japanese patients with hearing loss has not been reported.
Methods: Using denaturing high-performance liquid chromatography combined with direct sequencing and
cloning-sequencing, Japanese patients with prelingual (N = 54) or postlingual (N = 80) sensorineural hearing loss
not having pathogenic mutations of m.1555A > G and m.3243A > G nor GJB2 were subjected to mutational
analysis of mtDNA genes (12S rRNA, tRNA
Leu(UUR), tRNA
Ser(UCN), tRNA
Lys, tRNA
His, tRNA
Ser(AGY), and tRNA
Glu).
Results: We discovered 15 variants in 12S rRNA and one homoplasmic m.7501A > G variant in tRNA
Ser(UCN);n o
variants were detected in the other genes. Two criteria, namely the low frequency in the controls and the high
conservation among animals, selected the m.904C > T and the m.1105T > C variants in 12S rRNA as candidate
pathogenic mutations. Alterations in the secondary structures of the two variant transcripts as well as that of
m.7501A > G in tRNA
Ser(UCN) were predicted.
Conclusions: The m.904C > T variant was found to be a new candidate mutation associated with hearing loss. The
m.1105T > C variant is unlikely to be pathogenic. The pathogenicity of the homoplasmic m.7501T > A variant
awaits further study.
Background
Hearing loss manifests in more than 1 in 1000 persons
at birth, and the frequency increases subsequently to 3
in 1000 by 4 years of age [1,2]. Approximately 50 to
70% of congenital and childhood deafness is estimated
to be due to genetic mutations. In adults, the prevalence
of hereditary hearing impairment has been estimated to
be approximately 3.2 in 1000 [3]. Some of the mito-
chondrial DNA (mtDNA) genes, such as 12S rRNA,
tRNA
Leu(UUR),a n dtRNA
Ser(UCN),a r ek n o w nt ob e
responsible for hereditary hearing loss [4]. Among them,
the m.1555A > G mutation in 12S rRNA is found rela-
tively frequently (0.6-16%, depending on the ethnic
group) in aminoglycoside-induced, congenital, and late-
onset nonsyndromic hearing loss [4,5]. The m.1494C >
Tm u t a t i o ni n12S rRNA is also associated with amino-
glycoside-induced and nonsyndromic hearing loss [6,7].
The m.3243A > G mutation in tRNA
Leu(UUR) is asso-
ciated with late-onset nonsyndromic hearing loss [8,9],
maternally inherited diabetes and deafness (MIDD)
[10,11], and mitochondrial myopathy, encephalopathy,
lactic acidosis, stroke-like episodes (MELAS), which fre-
quently presents with hearing loss [12,13]. The m.7445A
> C/G/T [14-16], 7472insC [17], and 7510T > C muta-
tions [18] in tRNA
Ser(UCN) are also associated with
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hearing loss.
In addition, many other variants in 12S rRNA have
been proposed to be associated with hearing loss [4].
Some variants such as m.827A > G [19,20], 961T > C
[21], 961delT + Cn [21,22], 1005T > C [22], and 1095T
>Ci n12S rRNA [22-26] are not definitively related to
hearing loss, because they have been found in subjects
with normal hearing and/or are not conserved among
mammals [19,27-30]. Moreover, a variety of mitochon-
drial haplogroups often localize in specific ethnic
groups, making it difficult to determine whether the
mtDNA variants are associated directly with diseases,
indirectly as risk factors, or simply with rare subha-
plogroups [31-34]. Accumulating reports of various
novel mtDNA mutations associated with hearing loss
prompted us to evaluate these variants in patients with
hearing loss in Japan, where mtDNA mutation studies
have focused on a few limited nucleotide positions
[35,36].
A single cell contains hundreds of mitochondria, and
the mtDNA in each mitochondrion is occasionally het-
erogeneous, a feature called heteroplasmy [37]. The pro-
portion of pathogenic mutations of heteroplasmic
mtDNA is considered to be one of the reasons for the
wide range of severity of phenotypes seen in patients
with mitochondrial-related diseases, such as those
reported in the case of the m.3243A > G mutation
[38-40]. Denaturing high-performance liquid chromato-
graphy (dHPLC) is a sensitive method to detect hetero-
plasmic mutations that can be overlooked by simple
direct sequencing and comparison of the scanned peaks
or restriction fragment length polymorphism-PCR
[28,41]. In this study, we conducted a systematic muta-
tional analysis of mtDNA by dHPLC combined with
direct sequencing and cloning-sequencing in samples
from Japanese patients with hearing loss.
Methods
Subjects
Subjects with bilateral sensorineural hearing loss were
recruited by the National Tokyo Medical Center and
collaborating hospitals. Subjects’ medical histories were
obtained and physical examinations were performed to
exclude those subjects with syndromic symptoms, dis-
eases of the outer or/and middle ear, and environmental
factors related to hearing loss such as history of infec-
tious diseases, premature birth, and newborn meningitis.
Patients with a history of use of ototoxic drugs were
included in the study because these drugs are known to
be associated with mitochondrial hearing loss. Prior to
this study, the patients were confirmed not to have the
m.1555A > G and m.3243A > G mutations or not to be
diagnosed as having GJB2 -caused hearing loss, as
assessed by restriction fragment length polymorphism-
PCR or together with direct sequencing if the heterozy-
gotic 235delC mutation was detected in GJB2 [42,43].
The 134 subjects were classified into prelingual hearing
loss (onset before 5 years old, 20 males and 34 females)
or postlingual hearing loss (onset at 5 years old or later,
31 males and 49 females) [1]. The control group con-
sisted of 137 unrelated Japanese individuals with normal
hearing as examined by pure-tone audiometry. All sub-
jects or their parents gave prior informed consent for
participation in this study. This study was approved by
the ethics committee of National Tokyo Medical Center.
Screening for mtDNA mutations by dHPLC
DNA was extracted from blood samples using the Gen-
tra Puregene DNA isolation kit (QIAGEN, Hamburg,
Germany). Initially, whole mtDNA from each patient
was amplified in three overlapping fragments (1351-
8197, 6058-12770, and 11706-2258) [44] by LATaq
DNA polymerase (TaKaRa BIO, Shiga, Japan). PCR was
conducted at 94°C for 1 min followed by 30 cycles of
98°C for 10 s and 68°C for 6.5 min. Then, using the
P C Rp r o d u c t sa st e m p l a t e s ,v a r i a n t sw e r ea n a l y z e db y
the Mitoscreen assay kit (Transgenomic, Glasgow, UK).
We amplified the genes 12S rRNA, tRNA
Leu(UUR), tRNA-
Ser(UCN), tRNA
Lys, tRNA
His, tRNA
Ser(AGY),a n dtRNA
Glu,
for which mutations were reported to be associated with
hearing loss on the Hereditary Hearing Loss Homepage
[45] when the study was started. The PCR products
using primer sets MT4 (for 12S rRNA), MT6 (tRNA
Leu
(UUR)), MT10 (tRNA
Ser(UCN)), MT11 (tRNA
Lys), MT15
(tRNA
His and tRNA
Ser(AGY)), and MT18 (tRNA
Glu)w e r e
incubated with the appropriate restriction enzymes,
incubated for heteroduplex formation either with refer-
ence PCR products to detect homoplasmy or with their
own PCR products to detect heteroplasmy, then ana-
lyzed by dHPLC (WAVE system, Transgenomic) accord-
ing to the manufacturer’s protocols.
The reference mtDNA was derived from a Japanese
individual with normal hearing. Sequencing of the entire
reference mtDNA revealed 750A > G and 1438A > G
polymorphisms, and the mtDNA sequence was other-
wise comparable to the revised Cambridge Reference
sequence (AC_000021) [46,47]).
DNA sequencing
When homoplasmic or heteroplasmic variants were
detected, the PCR product was subjected to direct
sequencing by the BigDye Terminator ver. 3 cycle
sequencing kit and ABI genetic analyzer 3730 (Life
Technologies, Carlsbad, CA). To sequence 12S rRNA,a n
additional nested PCR product (656-1,266) was ampli-
fied with primers F (5’-tggtcctagcctttctattagctctt-3’)a n d
R( 5 ’-tggcggtatataggctgagca-3’). To sequence tRNA
Ser
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was amplified with primers F (5’-atgccccgacgttactcg-3’)
and R (5’- acctacttgcgctgcatgtg-3’). To determine the
proportion of heteroplasmic 1005T > C variant in the
12S rRNA, the nested PCR (656-1,266) product was
cloned and sequenced. Nested PCR was carried out by
replacing AmpliTaq Gold DNA polymerase with Pri-
meSTAR DNA polymerase, which has 3’-proofreading
activity (TaKaRa BIO), followed by the Zero Blunt
TOPO PCR cloning kit (Life Technologies). We
sequenced 54 clones derived from the proband mtDNA
and 24 clones derived from the mtDNA of each of five
siblings. Sequencing data were analyzed by SeqScape
ver2.6 (Life Technologies) and DNASIS Pro (Hitachisoft,
Tokyo, Japan). The sequencing results for each patient
were compared with the revised Cambridge Reference
sequence to identify mtDNA variants. The uniqueness
of each mutation was evaluated by comparison with the
mtSNP database [48], MITOMAP [49], and the Uppsala
mtDB database [50].
Prediction of pathogenicity of mtDNA variants
The variants were evaluated based on double selection
as proposed by Leveque and coworkers [51], with modi-
fication. Initially, we measured the frequencies of each
variant found in the controls in our study (N = 137)
and in the mtSNP database (N = 672, including: cente-
narians in Gifu, centenarians in Tokyo, type 2 diabetes
mellitus patients (without or with vascular disorders),
overweight young adult males, non-overweight young
adult males, Parkinson’s disease patients, and Alzhei-
mer’s disease patients in Japan). The variants with a fre-
quency of more than 3% in one of the groups were
considered as non-pathologic polymorphisms. We used
a frequency threshold lower than that previously used
(4%) [51] because the mtSNP database of Japanese indi-
viduals and the controls reflect the patient ethnic group
background more closely than the mtDB and therefore
requires a lower frequency threshold to exclude poly-
morphisms. The nucleotide conservation in each gene
from human and 50 mammalian species was evaluated
by ClustalW. The additional file lists the mammalian
species and the accession numbers of the mtDNA
(Additional File 1: Table S1). The variant frequencies in
the mtDB were calculated to determine if the low var-
iant frequencies measured in the controls reflect rare
haplotypes in the Japanese population and are more
common worldwide. All the variants were also analyzed
with PhyloTree (mtDNA tree Build 10) [52] to search
for previously characterized variants in haplogroups.
Pathogenicity of the variants was also evaluated by pre-
dicting the secondary structures of the mitochondrial
transcripts with or without the variant using Centroid
Fold [53,54].
Results
dHPLC screening and subsequent direct sequencing in
the patients identified 12 homoplasmic or heteroplasmic
variants in 12S rRNA and 1 homoplasmic variant in
tRNA
Ser(UCN) (Table 1). In addition, the 3 homoplasmic
variants, m.752C > T, 1009C > T, and 1107T > C in 12S
rRNA were detected in the controls by direct sequen-
cing. All the patients and the controls appeared to have
the non-pathogenic m.750A > G and 1438A > G var-
iants, as previously noted [49]. No tRNA
Glu, tRNA
Leu
(UUR), tRNA
Lys, tRNA
His,o rtRNA
Ser(AGY) variants were
detected. Table 1 lists the number of patients found
with each variant, the frequencies of the variants in the
controls and among Japanese individuals with various
clinical conditions (mtSNP, N = 672), previous reports
of the variants, and the frequencies of the variants in
the mtDB. We evaluated two criteria, namely that the
f r e q u e n c yo ft h ev a r i a n t sb e<3 %i nb o t ht h ec o n t r o l s
and in the Japanese database (mtSNP) and that the var-
iant nucleotide conserved by >50% among the 51 mam-
malian species we considered [51]; based on this
analysis, two 12S rRNA variants, m.904C > T and 1005T
> C, were selected as candidate pathogenic mutations
and subjected to further study. Although the homoplas-
mic m.7501T > A variant in tRNA
Ser(UCN) did not meet
the conservation criteria, it was also subjected to further
study because several other tRNA
Ser(UCN) mutations have
been reported to be associated with hearing loss,
whereas the m.7501T > A variant has not been studied
for its pathogenicity.
A novel homoplasmic m.904C > T variant in the12S
rRNA was found in a 46-year-old female patient (Figure
1A). She did not possess additional mtDNA pathogenic
mutations and showed prelingual, progressive hearing
loss with tinnitus. The patient was suspected of hearing
impairment as early as 4 years old and was diagnosed
with sensorineural hearing loss at age 11. The audio-
metric examination showed mild hearing loss at low fre-
quencies and no response at 1 kHz and higher
frequencies (Figure 1B). She had no response to an
otoacoustic emission test, indicating dysfunction of the
auditory outer hair cells. The patient had no history of
treatment with ototoxic drugs and did not suffer from
any other symptoms. The siblings also suffered from
prelingual, severe hearing loss (with similar ages of
onset and severity), but their parents had normal hear-
ing (Figure 1A). The patient bore two children with nor-
mal hearing. DNA samples were not obtained from
other family members. The secondary structure of the
variant 12S rRNA predicted by Centroid Fold suggested
that substitution of C > T (transcribed as U) at position
9 0 4o ft h e12S rRNA results in gross structural altera-
tion of the transcript region that includes nucleotide
positions 862 to 917, in addition to truncation of the
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Page 3 of 12Table 1 Mitochondrial DNA variants identified in this study
Gene Mutation Homo/
heteroplasmy
prelingual HL
(N = 54)
Late-onset HL
(N = 80)
Controls
(N = 137)
freq in
controls (%)
Japanese
(N = 672)
a
freq in
Japanese (%)
conservation
index
b
Previous
report
c
mtDB
c
(N = 2704)
freq in
mtDB (%)
12S
rRNA
663A > G homoplasmy 3 5 2 1.5 48 7.1 29/51 yes 86 3.2
709G > A homoplasmy 7 7 12 8.8 125 18.6 19/51 yes 444 16.4
750A > G homoplasmy 54 80 137 100.0 no data no data 49/51 yes 2682 96.7
752C > T homoplasmy 0 0 9 6.6 17 2.5 44/51 yes 20 0.7
827A > G homoplasmy 4 3 3 2.2 25 3.7 48/51 yes 54 2.0
904C > T homoplasmy 1 0 0 0.0 0 0.0 48/51 none 0 0.0
961insC homoplasmy 1 0 3 2.2 1 0.1 9/51 yes 37 2.0
961delT+
Cn
both 0 1 4(2)
d 2.9 no data no data 9/51 yes no data no data
1005T > C both 1 1(1) 1 0.7 1 0.1 33/51 yes 7 0.3
1009C > T homoplasmy 0 0 1 0.7 1 0.1 9/51 yes 2 0.1
1041A > G homoplasmy 0 4 5 3.6 11 1.6 26/51 yes 14 0.5
1107T > C homoplasmy 0 0 6 4.4 29 4.3 30/51 yes 34 1.26
1119T > C homoplasmy 1 2 7 5.1 20 3.0 20/51 yes 26 1.0
1382A > C homoplasmy 0 1 11 8.0 62 9.2 38/51 yes 65 2.4
1438A > G homoplasmy 54 80 137 100.0 662 98.5 46/51 yes 2620 96.9
tRNA
Ser
(UCN)
7501T > A homoplasmy 0 3 0 0.0 1 0.1 15/51 yes 1 0.0
Mitochondrial gene variants that met the criterion for association with hearing loss (HL) are underlined and in bold type.
aData from the mtSNP database [48].
bBased on the results of the multiple alignment by
ClustalW. See Additional File 1: Table S1 for information on the species used to calculate the sequence conservation.
cUppsala mtDB database [50].
dEach number in parentheses indicates the number of individuals
with a heteroplasmic variant.
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Figure 1 Pedigree of a family carrying the m.904C > T variant. (A) Pedigree of a family carrying the homoplasmic m.904C > T variant.
Individuals with hearing loss are indicated by filled symbols. The arrow indicates the proband. (B) Audiogram of the proband of m.904C > T.
Open circles with the line indicate the air conduction thresholds of the right ear; the X’s with dotted line indicate the air conduction thresholds
of the left ear; [, bone conduction thresholds of the right ear; ], bone conduction thresholds of the left ear. Arrows indicate the scale-out level of
hearing loss. (C, D) Secondary structures of wild-type 12S rRNA (C) and 12S rRNA with the m.904C > T (D) predicted by Centroid Fold. To the
right is shown an enlargement of the region of predicted secondary structures surrounding nucleotide positions including 904 and 1005 (bold
arrows with red circles). Positions 862, 917, 1021, and 1030 are marked by dashed arrows with black circles for easy comparison of the structural
changes. Each predicted base pair is indicated by a gradation of color (red to blue) corresponding to the base-pairing probability from 1 (red) to
0 (blue) according to Centroid Fold.
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Page 5 of 12stem-like structure from positions 1021 to 1030 (Figure
1C and 1D), implicating a significant role for 904C in
12S rRNA folding.
The homoplasmic m.1005T > C variant in the 12S
rRNA was found in a male patient with prelingual,
severe hearing loss (Figure 2A, B). The patient’ss p o u s e
had prelingual hearing loss owing to measles, and their
child also had prelingual hearing loss. The m.1005T > C
variant was not detected in the patient’ss p o u s eo r
daughter. DNA samples were not obtained from other
family members.
The heteroplasmic m.1005T > C variant together with
the homoplasmic mutation m.709G > A was detected in
am a l ep a t i e n tf r o mac o n s a n g u i n e o u sm a r r i a g eo fp a r -
ents with normal hearing (Figure 2C). In the proband
(III:3), onset of hearing loss and diabetes mellitus
occurred in his 40s. Among his five siblings, four (III:1,
2, 4, 6) also showed adult-onset hearing loss between
age 20 and 50 years, but they did not have diabetes mel-
litus. The fifth sibling suffered from infantile paralysis
and died at age 6 (III:5). Cloning of the fragment of 12S
rRNA, which demonstrated apparent heteroduplex for-
mation (Figure 2D, arrow), yielded 12 of 54 clones
(22%) with the m.1005T > C variant. However, the
m.1005T > C variant was not detected in 24 clones
derived from the mtDNA from each of these siblings,
indicating that the variant was absent in the siblings or
the frequency was less than 4%. The audiograms showed
severe to profound hearing loss in the siblings III:1, 2, 3,
and 4 (Figure 2E, F, 3A, B). The secondary structure of
the 12S rRNA variant predicted by Centroid Fold indi-
cated that the m.1005T > C induces a gross structural
alteration in the transcript, including nucleotide posi-
tions 862 to 917 (Figure 1C and 3C).
Three patients appeared to carry the homoplasmic
m.7501T > A variant in tRNA
Ser(UCN) (Figure 4A, C, E).
One female patient suffered from episodic vertigo from
age 27 years followed by tinnitus and fluctuant, moder-
ate progressive hearing loss, and she had no familial his-
tory of hearing loss (Figure 4A, B). Another female
patient suffered from tinnitus beginning at age 24 years
and had been exposed to streptomycin from age 36 to
37 for treatment of tuberculosis (Figure 4C, D). She suf-
fered from fluctuant, moderate hearing loss from her
50s and had no familial history of hearing loss. The
third patient was a male from a consanguineous mar-
riage of parents with normal hearing and showed non-
progressive, severe hearing loss from childhood without
tinnitus or vertigo (Figure 4E, F). Later, he was also
found to have X-linked spinal and bulbar muscular atro-
phy (SBMA/Kennedy-Alter-Sung disease/Kennedy’sd i s -
ease). In this family, six of seven siblings showed
hearing loss. Family members other than the proband
did not participate in this study. According to the
secondary structure prediction by Centroid Fold, the
m.7501T > A in tRNA
Ser(UCN) (which is transcribed as U
in the reverse direction) causes an elongation of the D-
arm in the transcript by reducing the size of the D-loop
of tRNA
Ser(UCN) (Figure 4G, H), which might affect bio-
synthesis of mitochondrial proteins [55].
Discussion
In our study, screening of mtDNA by dHPLC and direct
sequencing detected 15 variants in 12S rRNA and 1 var-
iant in tRNA
Ser(UCN). Comparison of the variant frequen-
cies in controls, assessment of nucleotide conservation
among mammalian species, and structural analysis of
the transcript was used to select candidate mutations
associated with hearing loss. No variants in tRNA
Leu
(UUR), tRNA
Lys, tRNA
His, tRNA
Ser(AGY),o rtRNA
Glu were
detected in the subjects studied here, suggesting that the
mutations in these genes associated with hearing loss
are not common in the Japanese population.
To our knowledge, the homoplasmic m.904C > T var-
iant in 12S rRNA has not been reported elsewhere. Lack
of symptoms in the maternal relatives does not exclude
mitochondrial transmission, because penetrance of 12S
rRNA mutations can be extremely low, as seen in the
m.1555A > G associated with hearing loss [56]. Conser-
vation of the nucleotides among mammals and gross
alteration of the predicted secondary structure of the
12S rRNA transcript suggest that the m.904C > T var-
iant might affect auditory function by changing the effi-
ciency with which mRNAs are transcribed to yield
mitochondrial proteins.
A patient with the homoplasmic m.1005T > C variant
in the 12S rRNA had a child with prelingual hearing
loss. The inheritance of hearing loss in the child is likely
due to the transmission of an autosomal mutation, not
mtDNA, from the male proband. Therefore, the data for
this family may not provide unequivocal information
about the pathogenicity of the m.1005T > C variant
[4,22,27,30].
Identification of the heteroplasmic m.1005T > C var-
iant in a patient with hearing loss is a novel finding,
because this variant has been known only as homoplas-
mic [22,27,30,34]. We did not verify that the heteroplas-
mic m.1005T > C variant was correlated with hearing
loss because four of five siblings of the proband had
hearing loss without carrying the variant, whereas it
might be associated with diabetes mellitus. However, it
is difficult to exclude the possibility of association of the
heteroplasmic variant detected in blood samples with
mitochondrial diseases such as deafness. Frequencies of
heteroplasmy of mtDNA vary considerably among tis-
sues in the same individual (for instance, [37,57,58]).
Therefore, it is possible that the frequency of the
m.1005T > C variant in the inner ear cells of the
Mutai et al. BMC Medical Genetics 2011, 12:135
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Figure 2 Pedigrees of families carrying the m.1005T > C variant. (A,B) Pedigree of a family carrying the homoplasmic m.1005T > C (A), and
the audiogram of the proband (B). (C-F) Pedigree of a family carrying heteroplasmic m.1005T > C (C), and the chromatogram of dHPLC of the
MT4 fragment of the proband (D). The arrows indicate split peaks of the fragment owing to the heteroplasmic m.1005T > C. Audiograms of the
siblings (III:1, 2) are shown in (E-F).
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Page 7 of 12siblings is much higher than in the blood cells and thus
may underlie the hearing loss.
Another finding in this study is that three patients
with postlingual hearing loss had the homoplasmic
m.7501T > A variant in tRNA
Ser (UCN). Various muta-
tions in tRNA
Ser(UCN), such as m.7445A > G [15,16],
7472insC [17,59], 7505T > C [60], 7510T > C [18], and
7511T > C [51,59,61], are associated with various types
of hearing loss (syndromic or nonsyndromic, prelingual
or late-onset), raising the possibility that the m.7501T >
A variant, reported elsewhere without detailed investiga-
tion [33], is also associated with hearing loss. The low
conservation of the variation at this position (29%
among mammals) does not support the pathogenicity of
the variant, in contrast to the much higher conservation
at m.7472A (61%), 7505A (98%), 7510T (78%), and
7511T (98%). On the other hand, the m.7501T > A var-
iant is predicted to modify the secondary structure of
the D-arm in the tRNA
Ser(UCN) transcript; the D-arm is
important for the stability of the transcript and the gen-
eral rate of mitochondrial protein synthesis [55]. Further
investigation, such as haplogroup analysis or generating
lymphoblastoid cell lines to measure endogenous
respiration rates, may help to define the pathogenicity of
the m.7501T > A variant.
All other variants found in this study, such as m.827A
> G, 961insC, and 961delT + Cn, which have been dis-
cussed elsewhere with respect to their pathogenicity
[21,22,27,30,62], were considered to be non-pathologic
polymorphisms because they were found frequently in
12S rRNA
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Figure 3 Pedigrees of families carrying the m.1005T > C variant (continued). (A,B) Audiograms of the siblings (III: 3, 4) of a family carrying
the heteroplasmic m.1005T > C (Figure 2C). (C) Predicted secondary structure of the 12S rRNA transcript with the m.1005T > C. To the right is
shown an enlargement of the region of predicted secondary structures surrounding nucleotide position 1005.
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Figure 4 Pedigrees of families carrying the m.7501T > A variant. (A-F) Pedigrees of three families carrying the homoplasmic m.7501T > A,
and audiograms of the probands (A and B, C and D, E and F). (G,H) Predicted secondary structure of the tRNA
Ser(UCN) transcript (G) and the
tRNA
Ser(UCN) with m.7501T > A (H). Because the gene is transcribed in the reverse direction, thymine at 7501 (G) and adenine (H) are indicated as
a and u, respectively (bold arrows).
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Page 9 of 12the controls. The other variants, m.663A > G, 709G > A,
750A > G, 752C > T, 1009C > T, 1041A > G, 1107T >
C, 1119T > C, 1382A > C, and 1438A > G, were fre-
quently detected in the controls and considered to be
nonpathogenic polymorphisms, which is in consistent
with a previous report [27]. The spectrum of variants of
mitochondrial genes in Japanese individuals was similar
to that in a Chinese population [27], for which most of
the variants detected in this study (other than the
m.904C > T and 7501T > A) have been reported. In
contrast, the spectrum was dissimilar to those in other
ethnic groups such as the Polish population [19,63]. Our
results indicate that ethnic background should be taken
into consideration when studying the pathogenicity of
mtDNA variants based on their frequencies in controls.
Conclusions
We sought to detect mitochondrial variants other than
m.1555A > G or 3243A > G mutations, which are
known to be related to hearing loss, by dHPLC, direct
sequencing, and cloning-sequencing in samples from
Japanese patients with hearing loss. The homoplasmic
m.904C > T variant in 12S rRNA was considered to be a
new candidate mutation associated with hearing loss.
The pathogenicity of the m.7501T > A variant in tRNA-
Ser(UCN) remains inconclusive, and other variants identi-
fied in this study, including the heteroplasmic m.1005T
> C variant, are not positively associated with hearing
loss. No variants were detected in the in tRNA
Leu(UUR),
tRNA
Lys, tRNA
His, tRNA
Ser(AGY), and tRNA
Glu.
Additional material
Additional file 1: Table S1. List of animal species and the accession
numbers of the mtDNA (GenBank) used to calculate nucleotide
conservation.
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